{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T15:36:37Z","timestamp":1770132997471,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"vor","delay-in-days":4634,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1111\/j.1538-7836.2010.03757.x","type":"journal-article","created":{"date-parts":[[2010,3,23]],"date-time":"2010-03-23T07:50:46Z","timestamp":1269330646000},"page":"730-736","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"title":["Comparative pharmacokinetics of plasma\u2010 and albumin\u2010free recombinant factor VIII in children and adults: the influence of blood sampling schedule on observed age\u2010related differences and implications for dose tailoring"],"prefix":"10.1016","volume":"8","author":[{"given":"S.","family":"BJ\u00d6RKMAN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.S.","family":"BLANCHETTE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"FISCHER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"OH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"SPOTTS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"SCHROTH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"FRITSCH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"PATRONE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.M.","family":"EWENSTEIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.W.","family":"COLLINS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl","key":"10.1111\/j.1538-7836.2010.03757.x_bb0010","first-page":"5","article-title":"Haemophilia in Sweden VII. Incidence, treatment and prophylaxis of arthropathy and other musculo\u2010skeletal manifestations of haemophilia A and B","volume":"77","author":"Ahlberg","year":"1965","journal-title":"Acta Orthop Scand"},{"key":"10.1111\/j.1538-7836.2010.03757.x_bb0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2796.1992.tb00546.x","article-title":"Twenty\u2010five years\u2019 experience of prophylactic treatment in severe haemophilia A and B","volume":"232","author":"Nilsson","year":"1992","journal-title":"J Intern Med"},{"key":"10.1111\/j.1538-7836.2010.03757.x_bb0020","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1538-7836.2008.03270.x","article-title":"Break\u2010through bleeding in relation to predicted factor VIII levels in patients receiving prophylactic treatment for severe haemophilia A","volume":"7","author":"Collins","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2010.03757.x_bb0025","first-page":"95","article-title":"Individualizing of factor VIII dosage","volume":"9","author":"Messori","year":"1984","journal-title":"J Clin Hosp Pharm"},{"key":"10.1111\/j.1538-7836.2010.03757.x_bb0030","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/00003088-198713060-00002","article-title":"Clinical pharmacokinetics of factor VIII in patients with classic haemophilia","volume":"13","author":"Messori","year":"1987","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/j.1538-7836.2010.03757.x_bb0035","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1600-0609.1993.tb00638.x","article-title":"Pharmacokinetic dosing in prophylactic treatment of hemophilia A","volume":"51","author":"Carlsson","year":"1993","journal-title":"Eur J Haematol"},{"key":"10.1111\/j.1538-7836.2010.03757.x_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2516.1997.00074.x","article-title":"The pharmacokinetics of factor VIII and factor IX: methodology, pitfalls and applications","volume":"3","author":"Bj\u00f6rkman","year":"1997","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2010.03757.x_bb0045","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1046\/j.1365-2516.1997.00091.x","article-title":"Improved cost\u2010effectiveness by pharmacokinetic dosing of factor VIII in prophylactic treatment of haemophilia A","volume":"3","author":"Carlsson","year":"1997","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2010.03757.x_bb0050","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2165\/00003088-200140110-00003","article-title":"Pharmacokinetics of coagulation factors: clinical relevance for patients with haemophilia","volume":"40","author":"Bj\u00f6rkman","year":"2001","journal-title":"Clin Pharmacokinet"},{"issue":"Suppl. 1","key":"10.1111\/j.1538-7836.2010.03757.x_bb0055","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1365-2516.9.s1.4.x","article-title":"Prophylactic dosing of factor VIII and factor IX from a clinical pharmacokinetic perspective","volume":"9","author":"Bj\u00f6rkman","year":"2003","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2010.03757.x_bb0060","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2516.2005.01149.x","article-title":"Use of pharmacokinetics in the coagulation factor treatment of patients with haemophilia","volume":"11","author":"Shapiro","year":"2005","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2010.03757.x_bb0065","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1600-0609.1985.tb00739.x","article-title":"Kinetic evaluation of four factor VIII concentrates by model\u2010independent methods","volume":"34","author":"Matucci","year":"1985","journal-title":"Scand J Haematol"},{"key":"10.1111\/j.1538-7836.2010.03757.x_bb0070","first-page":"494","article-title":"Factor VIII half\u2010life and clinical phenotype of severe hemophilia A","volume":"90","author":"Van Dijk","year":"2005","journal-title":"Haematologica"},{"key":"10.1111\/j.1538-7836.2010.03757.x_bb0075","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2516.2006.01333.x","article-title":"Pharmacokinetics of recombinant factor VIII (Kogenate\u2010FS) in children and causes of inter\u2010patient pharmacokinetic variability","volume":"12","author":"Barnes","year":"2006","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2010.03757.x_bb0080","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1538-7836.2008.03032.x","article-title":"Plasma and albumin\u2010free recombinant factor VIII: pharmacokinetics, efficacy and safety in previously treated pediatric patients","volume":"6","author":"Blanchette","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2010.03757.x_bb0085","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s00228-009-0676-x","article-title":"Pharmacokinetics and dose requirements of factor VIII over the age range of 3\u201374 years: a population analysis based on 50 patients with long\u2010term prophylactic treatment for haemophilia A","volume":"65","author":"Bj\u00f6rkman","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/j.1538-7836.2010.03757.x_bb0090","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/jcp.35.3.289","article-title":"Effect of height and weight on the in vivo recovery of transfused factor VIII C","volume":"35","author":"Aronstam","year":"1982","journal-title":"J Clin Pathol"},{"key":"10.1111\/j.1538-7836.2010.03757.x_bb0095","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00003088-199222050-00005","article-title":"Pharmacokinetics of factor VIII in humans. Obtaining clinically relevant data from comparative studies","volume":"22","author":"Bj\u00f6rkman","year":"1992","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/j.1538-7836.2010.03757.x_bb0100","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1055\/s-0038-1646423","article-title":"The design and analysis of half\u2010life and recovery studies for factor VIII and factor IX. Factor VIII\/Factor IX Scientific and Standardization Committee of the International Society for Thrombosis and Haemostasis","volume":"66","author":"Morfini","year":"1991","journal-title":"Thromb Haemost"},{"issue":"Suppl. 2","key":"10.1111\/j.1538-7836.2010.03757.x_bb0105","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1046\/j.1351-8216.2002.00136.x","article-title":"Comparative pharmacokinetic studies in haemophilia","volume":"8","author":"Morfini","year":"2002","journal-title":"Haemophilia"},{"issue":"Suppl. 3","key":"10.1111\/j.1538-7836.2010.03757.x_bb0110","first-page":"1","article-title":"The pharmacokinetics of coagulation factors","volume":"12","author":"Lee","year":"2006","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2010.03757.x_bb0115","unstructured":"Lee M, Morfini M, Schulman S, Ingerslev J and the Factor VIII\/Factor IX Scientific and Standardization Committee of the International Society for Thrombosis and Haemostasis. The design and analysis of pharmacokinetic studies of coagulation factors. http:\/\/www.isth.org\/Publications\/OfficialCommunications\/Factor8and9\/Pharmacokinetic.aspx. Accessed 24 July 2009."},{"key":"10.1111\/j.1538-7836.2010.03757.x_bb0120","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2516.2004.00932.x","article-title":"Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma\/albumin\u2010free method: pharmacokinetics, efficacy, and safety in previously treated patients with haemophilia A","volume":"10","author":"Tarantino","year":"2004","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2010.03757.x_bb0125","first-page":"745","article-title":"A two\u2010phase linear regression model for biologic half\u2010life data","volume":"115","author":"Lee","year":"1990","journal-title":"J Lab Clin Med"},{"key":"10.1111\/j.1538-7836.2010.03757.x_bb0130","unstructured":"Halls S. B. About arithmetic formulas for calculating ideal body weight. http:\/\/www.halls.md\/ideal\u2010weight\/devine.htm. Accessed 29 October 2005, 2 November 2007."},{"key":"10.1111\/j.1538-7836.2010.03757.x_bb0135","unstructured":"National Center for Health Statistics. National Health and Nutrition Examination survey, CDC growth charts: United States. http:\/\/www.cdc.gov\/growthcharts\/. Accessed 31 January 2010."},{"key":"10.1111\/j.1538-7836.2010.03757.x_bb0140","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1055\/s-0038-1655957","article-title":"Recombinant, B\u2010domain deleted factor VIII (r\u2010VIII SQ): pharmacokinetics and initial safety aspects in hemophilia A patients","volume":"77","author":"Fijnvandraat","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2010.03757.x_bb0145","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJM199012273232604","article-title":"Human recombinant DNA\u2010derived antihemophilic factor (factor VIII) in the treatment of hemophilia A. recombinant Factor VIII Study Group","volume":"323","author":"Schwartz","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2010.03757.x_bb0150","first-page":"29","article-title":"The pharmacokinetics of recombinant factor VIII. The rFactor VIII Clinical Trial Group","volume":"28","author":"Harrison","year":"1991","journal-title":"Semin Hematol"},{"key":"10.1111\/j.1538-7836.2010.03757.x_bb0155","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2516.2006.01401.x","article-title":"In vivo recovery of factor VIII and factor IX: intra\u2010 and interindividual variance in a clinical setting","volume":"13","author":"Bj\u00f6rkman","year":"2007","journal-title":"Haemophilia"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2010.03757.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622113231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622113231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2010.03757.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:52:40Z","timestamp":1761533560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622113231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S1538783622113231"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2010.03757.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative pharmacokinetics of plasma\u2010 and albumin\u2010free recombinant factor VIII in children and adults: the influence of blood sampling schedule on observed age\u2010related differences and implications for dose tailoring","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2010.03757.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}